Evaluating the ability to detect change of health-related quality of life in children with Hodgkin disease

Cancer

Volumn 116, Issue 6, 2010, Pages 1608-1614

  Klaassen, Robert J ^a   Krahn, Murray ^a   Gaboury, Isabelle ^b   Hughes, Joanna ^b   Anderson, Ronald ^c   Grundy, Paul ^d   Ali, S Kaiser ^e   Jardine, Lawrence ^f   Abla, Oussama ^g   Silva, Mariana ^h   Barnard, Dorothy ⁱ   Cappelli, Mario ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c ALBERTA CHILDREN'S HOSPITAL   (Canada)

^d STOLLERY CHILDREN S HOSPITAL   (Canada)

^e Saskatoon Cancer Center   (Canada)

^f Children's Hospital   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h QUEEN S UNIVERSITY   (Canada)

ⁱ IWK HEALTH CENTRE   (Canada)

Author keywords

Evaluation study; Hodgkin disease; Outcome measures; Pediatrics; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADOLESCENT; CHILD; FEMALE; HEALTH STATUS; HODGKIN DISEASE; HUMANS; MALE; PSYCHOMETRICS; QUALITY OF LIFE;

EID: 77949382132     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24883     Document Type: Article

References (21)

1. Villeneuve PJ, Raman S, Leclerc JM, Huchcroft S, Dryer D, Morrison H. Survival rates among Canadian children and teenagers with cancer diagnosed between 1985 and 1988. Cancer Prev Control. 1998;2:15-22.
2. Ross JA, Severson RK, Pollock BH, Robison LL. Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer. 1996;77:201-207.
3. Barr RD, Furlong W, Dawson S, et al. An assessment of global health status in survivors of acute lymphoblastic leukemia in childhood. Am J Pediatr Hematol Oncol. 1993;15: 284-290.
4. Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care. 1996;34:702-722.
5. Seid M, Varni JW, Rode CA, Katz ER. The pediatric cancer quality of life inventory: A modular approach to measuring health-related quality of life in children with cancer. Int J Cancer Suppl. 1999;12:71-76.
6. Varni JW, Katz ER, Seid M, Quiggins DJ, Friedman-Bender A, Castro CM. The Pediatric Cancer Quality of Life Inventory (PCQL). I. Instrument development, descriptive statistics, and cross-informant variance. J Behav Med. 1998;21:179-204.
7. Tebbi CK, London WB, Friedman D, et al. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. J Clin Oncol. 2007;25:493-500.
8. Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3:329-341.
9. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41:1403-149.
10. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer. 2002;94:2090-2106.
11. Boyle MH, Furlong W, Feeny D, Torrance GW, Hatcher J. Reliability of the Health Utilities Index-Mark III used in the 1991 cycle 6 Canadian General Social Survey Health Questionnaire. Qual Life Res. 1995;4:249-257.
12. Trudel JG, Rivard M, Dobkin PL, Leclerc JM, Robaey P. Psychometric properties of the Health Utilities Index Mark 2 system in paediatric oncology patients. Qual Life Res. 1998;7:421-432.
13. Krabbe PF, Essink-Bot ML, Bonsel GJ. The comparability and reliability of 5 health-state valuation methods. Soc Sci Med. 1997;45:1641-1652.
14. Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR. The measurement of performance in childhood cancer patients. Cancer. 1987;60:1651-166.
15. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality of life instrument. In: Spilker B. Quality of life and pharmacoeconomics in clinical trials, 2nd ed. Philadelphia: Lippincott Raven; 1996:49-56.
16. Deyo RA, Diehr P, Patrick DL. Reproductibility and responsiveness of health status measures: statistics and strategies for evaluation. Controlled Clin Trials. 1991;12(suppl 4):142S-58S.
17. Cohen J. Statistical power analysis for the behavioral sciences, 2nd ed. ed. Hillsdale, NJ: Lawrence Earlbaum Associates; 1988.
18. Banks BA, Barrowman NJ, Klaassen R. Health-related quality of life: changes in children undergoing chemotherapy. J Pediatr Hematol Oncol. 2008;30:292-297.
19. Langfitt JT, Vickrey BG, McDermott MP, et al. Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy. Qual Life Res. 2006;15:899-914.
20. Hatoum HT, Brazier JE, Akhras KS. Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. Value Health. 2004;7:602-609.
21. Feeny D, Wu L, Eng K. Comparing short form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients. Qual Life Res. 2004;13:1659-1670.